Regenerative Periodontal Surgery is provided to achieve bony infill in the crater or infra-bony defect associated with your tooth. This surgery aims to improve the long-term prognosis for your tooth.
Various regenerative materials may be used, such as human or bovine-derived bone with porcine-derived collagen membrane. The human or bovine bone serves as a filler in the bony defect and is covered by a membrane to prevent gum tissue from invading the space. This allows your own stem cells and progenitor cells from the periodontal ligament to infiltrate the area where you have lost bone and regenerate new bone, cementum, and periodontal ligament.
Alternatively, a biologically active agent, Enamel Matrix Derivative, may be used, which consists of porcine-derived amelogenins that mimic human amelogenins. These amelogenins are laid down during initial tooth development.
These regenerative materials have a substantiated track record with no reports of disease transmission to a patient anywhere in the world. There have been no reports of allergic reactions, and these materials are used routinely in periodontal surgical procedures.
The response to Regenerative Periodontal Surgery will be evaluated both clinically and radiographically six months after the procedure.
